Fisetin

Strong mouse lifespan data, but the one human pilot study found genuinely mixed results

Extended lifespan in aged mice in a landmark 2018 study

Human pilot data doesn't support anti-aging claims yet

Important: These statements have not been evaluated by the FDA. This information is not intended to diagnose, treat, cure, or prevent any disease. Always consult your physician before starting any supplement.

Overview

Fisetin is a natural flavonoid found in small amounts in strawberries, apples, persimmons, and onions, and it has become one of the more talked-about ingredients in the "longevity supplement" category under the label senolytic — a compound studied for its ability to selectively clear senescent cells, old and damaged cells that stop dividing but linger in tissue and are thought to contribute to age-related decline.

The interest traces back to a genuinely striking 2018 study that identified fisetin as the most potent senolytic among ten tested flavonoids and found it extended both median and maximum lifespan in aged mice. That's real, well-cited research — but it's mouse research. This is a case worth being especially direct about: the one available human pilot study on fisetin and biological aging found results that don't currently support the anti-aging claims built around it, and its own authors said so plainly.

What the Research Actually Shows

Strong Mouse Lifespan Data

A 2018 study found fisetin was the most potent senolytic tested and extended median and maximum lifespan in aged mice.

Cell & Tissue-Level Senescence Reduction

Reduced senescence markers in multiple mouse tissues and in human adipose tissue explants studied outside the body.

Favorable Short-Term Safety Signal

Small human trials using short, intermittent dosing protocols have not reported significant toxicity to date.

Human Anti-Aging Effect Not Yet Established

The one available human pilot study found mixed results and did not support the anti-aging claims common in fisetin marketing.

Typical Dosage

Human Pilot Study Dose

500mg/day, 1 week per month

Intermittent "hit-and-run" dosing pattern, reflecting the proposed senolytic mechanism

What the Trial Found

Mixed results after 6 months

4 of 10 improved, 5 of 10 worsened, 1 unchanged — not a clear benefit

Pro Tips

Treat this as an ingredient to watch, not one with proven human anti-aging benefits yet
Be skeptical of marketing that leans on the 2018 mouse study without mentioning the mixed 2024 human pilot data
If you try it anyway, intermittent dosing (days per month, not daily) reflects the senolytic "hit-and-run" theory used in available human trials
Larger, longer human trials are actively underway — worth checking back as this research matures

Research Snapshot

A 2024 pilot study gave 10 healthy adults (ages 53-72) 500mg of fisetin one week per month for six months and measured change in biological age using an epigenetic ("TruAge") test. Four of ten participants showed reduced biological aging, five of ten showed an increase, and one showed no change, with no statistically significant change in telomere length. The study's own authors concluded that taking fisetin as an anti-aging agent is not recommended until more extensive research is done — a notably honest conclusion given how the ingredient is often marketed.

Sources: Lee & Burns, Alternative Therapies in Health and Medicine (2024) · Yousefzadeh et al., EBioMedicine (2018)

How Fisetin Compares

Ingredient	Best For	Key Difference
Fisetin	Senolytic / Cellular Aging	Strong mouse data, genuinely mixed human pilot results
Urolithin A	Mitochondrial & Muscle Health	A positive, randomized human trial with real muscle-strength outcomes
Spermidine	Autophagy, Memory	A small but positive human memory trial
NMN / Nicotinamide Riboside	NAD+ Support	Multiple positive human trials on the biomarker itself

These are the most common comparisons our customers ask about in-store.

If You're Going to Try It Anyway

Longevity Research Stack

Fisetin + Urolithin A + Spermidine

Combines several cellular-aging-focused compounds with varying levels of human evidence

Antioxidant Foundation Stack

Fisetin + Quercetin + Resveratrol

Other flavonoid antioxidants sometimes combined in senolytic-focused protocols

More Evidence-Backed Alternative

Urolithin A + Creatine + Omega-3

If you want a longevity-adjacent stack with stronger current human trial support

Frequently Asked Questions

Does fisetin actually slow aging in humans?

The honest answer is that we don't know yet, and the one small human pilot study available found genuinely mixed results. A 2024 pilot study gave 10 healthy adults 500mg of fisetin one week per month for six months and measured biological age using an epigenetic test: 4 of 10 showed reduced biological aging, 5 of 10 showed an increase, and 1 showed no change. The study's own authors concluded fisetin isn't recommended as an anti-aging agent until more extensive research is done.

What is a senolytic, and why is fisetin called one?

Senolytics are compounds studied for their ability to selectively clear senescent cells — old, damaged cells that stop dividing but don't die, and are thought to contribute to age-related tissue dysfunction. In a foundational 2018 study, fisetin was identified as the most potent senolytic among ten tested flavonoids in cell and mouse models, and chronic treatment extended both median and maximum lifespan in aged mice.

Is fisetin safe to take?

Available human trials, including short intermittent-dosing protocols, have not reported significant toxicity, and it's generally been well tolerated. One early trial did note a transient reduction in kidney function in a single subject that resolved on its own. As with any newer supplement without long-term human safety data, a cautious approach and a conversation with your doctor is reasonable.

Sources & References

1. Yousefzadeh, M.J., Zhu, Y., McGowan, S.J., et al. (2018). Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine, 36, 18–28.

2. Lee, E., & Burns, M. (2024). The effects of fisetin on reducing biological aging: a pilot study. Alternative Therapies in Health and Medicine, 30(9), 6–10.

All references are peer-reviewed studies or position stands from reputable organizations.